Tubulysin ATubulysin A
MedChemExpress (MCE)
HY-15995
205304-86-5
TubA
99.08%
-20°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months
-20°C, 1 month (protect from light, stored under nitrogen)
Room temperature in continental US
may vary elsewhere.
Tubulysin A (TubA) is an anticancer and antiangiogenic agent with anti-microtubule, anti-mitosis and anti-proliferative activity against a variety of cancer cells with IC50 values in the pmol range. It can induce apoptosis of cancer cells and has no effect on normal cells. Tubulysins are a group of potent cytotoxins consisting of nine members (A-I). Tubulysin A can synthesize ADC as ADC Cytotoxin.
The IC50 values of Tubulysin A in the NCI-H1299 (lung), HT-29 (colon) and A2780 (ovary) cell lines are 3, 1 and 2 nmol/L, respectively[4]. The IC50 values of Tubulysin A against L929 (mouse fibroblast) and KB-V1 (human cervical cancer multidrug resistant cell line) cells were 0.07 and 1.4 ng/ml, respectively[1]. Tubulysin A (1 nM, 10 nM
24h) has an antiangiogenic effect in HUVEC cells with IC50 values of 2.07-2.97 nM[1]. Tubulysin A (5h) can inhibit cell migration in HUVEC cells with IC50 value of 2.26 nM[1]. Tubulysin A (72h) can inhibit cell growth in HUVEC cells with GI50 value of 0.34 nM[1].
Tubulysin A (0.04 mg/kg, 0.06 mg/kg
Intraperitoneal (i.p.)
once daily for 4 days) can inhibit the growth of tumor cells in mouse xenotransplantation model[1].
Traditional Cytotoxic Agents
| | | |
| | | | | |
[1]. Kaur G, et al. Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product. Biochem J. 2006 Jun 1
396(2):235-42. [Content Brief]
[2]. Sasse F, et al. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo). 2000 Sep
53(9):879-85. [Content Brief]
[3]. Khalil MW, et al. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria. Chembiochem. 2006 Apr
7(4):678-83. [Content Brief]
[4]. Schluep T, et al. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity. Clin Cancer Res. 2009 Jan 1
15(1):181-9. [Content Brief]